Can CRPS Spread to Organs? The Neurological Facts

CRPS does not invade organs the way a cancer metastasizes, but the condition’s effects reach well beyond the limb where it starts. Complex regional pain syndrome is fundamentally a disorder of the nervous system, and because the same autonomic nerves that malfunction in a CRPS-affected hand or foot also regulate heart rate, digestion, blood pressure, and blood flow to deep tissues, the syndrome can produce measurable disturbances in organ function. The distinction matters: CRPS tissue damage stays in the limbs, but autonomic fallout can ripple through the body in ways that mimic organ-level disease.

How CRPS Spreads Between Limbs

Before asking whether CRPS can reach organs, it helps to understand how it moves at all. When CRPS spreads, it almost always travels to another limb rather than to internal structures. A study of 72 patients who developed CRPS in a second limb found that about half showed a contralateral pattern (the opposite hand after starting in one hand, for instance), roughly a third showed an ipsilateral pattern (same side, different limb), and only about one in seven spread diagonally. Diagonal spread was almost always preceded by a new injury to the second site, while contralateral and ipsilateral spread often occurred on its own.¹

An earlier analysis of 27 patients identified three overlapping spread types. Every patient in the group experienced contiguous spread, meaning the affected area gradually enlarged from the original site. About 70% also developed CRPS at a distant, non-contiguous location, such as a hand after the condition first appeared in a foot. And about 15% experienced mirror-image spread on the opposite side of the body in a location that closely matched the original.² These patterns strongly suggest that spread is governed by central nervous system mechanisms rather than by local tissue injury radiating outward, which is why researchers have long suspected that the brain and spinal cord play a central role in how the syndrome evolves.

Why the Autonomic Nervous System Is the Bridge

The autonomic nervous system controls functions you never have to think about: heart rhythm, gut motility, blood vessel tone, sweating, temperature regulation. In CRPS, this system goes haywire. Research identifies sympathetic dysregulation and alterations in how the brain processes sensory information as key mechanisms behind CRPS symptoms.³ A focused literature review found that immune reactions, changes in receptor populations on nerve endings (including an increase in the receptors that respond to adrenaline), and shifts in how the brain drives sympathetic activity all contribute to both regional and body-wide disturbances in sympathetic function.⁴

The word “systemic” is important here. The sympathetic nerves that control blood vessel diameter in your affected hand are part of the same network that controls blood vessel diameter everywhere else, including in the gut wall, the kidneys, and the heart muscle. When the central autonomic drive changes, the effects are not neatly confined to one limb. Blood vessels throughout the body are controlled predominantly by the sympathetic nervous system to maintain blood pressure and organ blood flow, and pathological conditions that damage one or both branches of the autonomic system can disrupt that regulation broadly.⁵

Neurogenic Inflammation and How It Escapes the Limb

A hallmark of CRPS is neurogenic inflammation, a type of inflammation driven by the nerves themselves rather than by infection or tissue injury. When pain-sensing nerve fibers fire, they release signaling molecules, primarily calcitonin gene-related peptide (CGRP) and substance P. These molecules cause blood vessels to dilate and fluid to leak into surrounding tissue, producing the swelling, redness, and warmth that characterize early CRPS.⁶ Research has also linked some seemingly non-inflammatory symptoms, such as excessive sweating and cold skin, to these same neuropeptide signals.⁷

A broader review of the field examined neuroinflammation’s role from multiple angles, including the behavior of immune cells, cytokines, and glial cells in the nervous system.⁸ What matters for the organ question is that neurogenic inflammation is not inherently local. CGRP and substance P circulate in the blood, and when their release is amplified by sensitized nerves and an overactive immune response, the downstream effects can touch blood vessels and tissues far from the original injury site. This does not mean the organs develop CRPS. It means they can be caught in the crossfire of a nervous system that has lost its normal regulatory balance.

Gastrointestinal Symptoms in CRPS Patients

The gut is one of the clearest examples of organ-level impact. A study surveyed CRPS patients who did not have thyroid disease and were not on opioid painkillers (both of which independently cause GI problems). Even after excluding those confounders, about 58% of patients reported at least one gastrointestinal symptom. Roughly 29% experienced nausea, 24% had constipation, 21% reported indigestion, and 17% described difficulty swallowing.⁹ The researchers concluded that the autonomic dysfunction seen in CRPS was the likely bridge between a limb condition and widespread digestive trouble.

These are not trivial complaints. Difficulty swallowing and chronic nausea affect nutrition, energy, and quality of life. Many CRPS patients are already on medications that further slow the gut, so when autonomic dysfunction piles on top, the combined effect can be debilitating. If you have CRPS and are experiencing persistent GI symptoms that your doctor has not connected to the syndrome, it is worth raising the possibility.

Cardiovascular Effects

The heart is another organ clearly influenced by CRPS-related autonomic dysfunction. A controlled study found that CRPS patients had a faster resting heart rate and reduced heart rate variability compared with healthy subjects, both at rest and during mental and physical stress.¹⁰ Heart rate variability is a measure of how flexibly the heart adjusts beat to beat; lower variability generally indicates that the autonomic nervous system is not responding well to the body’s changing demands. In healthy people, the heart speeds up and slows down constantly in tiny increments. In CRPS patients, the heart’s rhythm becomes more rigid and predictable, which paradoxically is a sign that the system is under strain.

A separate study went further, showing that CRPS patients had an altered balance between the sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) branches of the autonomic nervous system, with the sympathetic side dominating. Their blood pressure regulation was also impaired: baroreceptor sensitivity, the body’s ability to correct blood pressure moment to moment, was abnormally low. When pain was successfully treated, however, these cardiovascular measures improved significantly.¹¹ That finding is important because it suggests the cardiovascular effects are a consequence of the pain state and its autonomic disruption, not a separate disease process. Treat the CRPS effectively and the heart regulation tends to recover.

Chest Pain and Respiratory Function

Chest pain is common enough in CRPS to have drawn specific investigation. One study found that 94% of CRPS patients reported a history of chest pain, compared with just 19% of healthy controls. Patients identified raising their arm as a major trigger, and pressure testing revealed significantly increased sensitivity across the chest wall.¹² The researchers attributed this to sensitization of the intercostobrachial nerve, which runs from the armpit area across the chest. When CRPS in an upper limb sensitizes nerves that share territory with chest-wall nerves, pain can radiate in ways that alarm both patients and their doctors.

In rare cases, the chest wall itself becomes involved more directly. A case report described a CRPS patient who developed dystonia (involuntary muscle contraction) in the chest wall muscles. Pulmonary function testing showed both restrictive and obstructive features despite the absence of any underlying heart or lung disease.¹³ In plain terms, the muscles around the ribs were contracting abnormally and interfering with the patient’s ability to breathe, not because the lungs were diseased but because the nervous system was sending the wrong signals to the muscles surrounding them. This is a rare complication, but it illustrates how CRPS can produce organ-like symptoms without the organs themselves being structurally diseased.

Bladder Dysfunction and Overlapping Symptoms

Urinary problems have also been reported alongside CRPS-like symptoms, though the research here is thinner. A clinical study of patients with chronic bladder dysfunction found that 22 out of 213 had reproducible associated symptoms in areas typical of CRPS, including the hands, feet, and jaw. The severity of bladder dysfunction and the associated limb symptoms appeared to track together, and when treatment improved one, the other tended to improve as well.¹⁴ This does not prove CRPS caused the bladder problems. It does suggest that both may share a common root in autonomic dysregulation, and it gives clinicians a reason to look for connections between limb pain syndromes and pelvic organ complaints.

Microvascular Damage in the Affected Limb

While the organ-level effects described above are mostly functional disruptions caused by autonomic misfiring, there is evidence that CRPS can cause structural damage at the tissue level within the affected limb itself. Muscle tissue taken from severely affected limbs that had been amputated showed collapsed capillary channels, severely thickened vessel walls, signs of oxidative stress, and atrophied muscle fibers.¹⁵ Even in intact CRPS limbs, researchers have observed a puzzling pattern: blood flow through the large arteries feeding the limb is actually high, but oxygen consumption by the tissues is low and lactate production is elevated, a combination that points to tissue-level oxygen starvation despite adequate supply. The problem appears to be in the tiny capillaries and in shunting, where blood bypasses the tissue beds that need it.

Amputation specimens obviously represent the extreme end of CRPS severity, so these findings cannot be generalized to every patient. But the microvascular picture is worth understanding because it explains why some CRPS limbs develop trophic changes: thinning skin, brittle nails, muscle wasting, bone loss. The tissue is literally being starved of oxygen at the capillary level. Whether this kind of microvascular injury extends systemically, to organ beds, has not been established. The current evidence confines it to the affected limb.

The Autoimmune Angle

One of the more intriguing lines of CRPS research involves autoantibodies, immune proteins that mistakenly target the body’s own receptors. Researchers have identified antibodies in a subset of CRPS patients that bind to and activate two specific receptors: the beta-2 adrenergic receptor and the muscarinic-2 receptor.¹⁶ Both receptors play important roles in autonomic nervous system function throughout the body. Follow-up laboratory work showed that these autoantibodies can cause inflammation and functional disturbances in blood vessel cells grown in a dish.¹⁷

A more recent cross-sectional study measured levels of these autoantibodies in CRPS patients, other chronic pain patients, and healthy controls. Antibodies against the muscarinic-2 receptor were elevated in both CRPS and other chronic pain groups compared to healthy individuals. About 55% of CRPS patients were seropositive for at least one type of autoantibody, compared with 44% in other chronic pain and 22% in healthy controls. However, the autoantibody levels did not significantly differ between CRPS patients and other chronic pain patients, meaning these antibodies may reflect chronic pain broadly rather than being unique to CRPS.¹⁸

Why does this matter for the organ question? Because autoantibodies circulate everywhere. If they are activating autonomic receptors on blood vessel walls in the affected limb, they could theoretically do the same thing to blood vessels in the heart, gut, or kidneys. This is still speculative: no study has demonstrated organ damage driven by CRPS-associated autoantibodies. But the autoimmune pathway provides a plausible mechanism by which CRPS could, in principle, have body-wide vascular effects beyond what autonomic nerve misfiring alone would produce.

Small Fiber Neuropathy and the Systemic Picture

Another piece of the puzzle is the finding that many CRPS patients have lost small-diameter nerve fibers in the affected area. A biopsy study found that nerve fiber density at CRPS-affected sites was reduced by an average of about 29% compared to the patient’s own unaffected side, and healthy controls showed no such reduction at painful sites, ruling out disuse or prior surgery as the cause.¹⁹ A related analysis proposed that persistent CRPS is essentially a post-traumatic small-fiber neuropathy, noting that most classic CRPS features, including spreading pain, skin sensitivity, vascular instability, bone thinning, swelling, and sweating abnormalities, can be explained by dysfunction of these tiny nerve fibers.²⁰

Small fiber neuropathies that are not CRPS, such as those caused by diabetes or autoimmune disease, are well known to produce systemic autonomic symptoms: lightheadedness on standing, abnormal sweating patterns, GI dysmotility, and bladder problems. If CRPS involves a similar kind of small fiber damage, even if it starts locally, the overlap with systemic autonomic symptoms becomes easier to understand. The nerves that are degenerating are the same type that regulate organ function elsewhere in the body.

Brain Changes and the Stress Axis

CRPS also leaves a mark on the brain. Imaging studies have found that the area of the brain’s sensory cortex devoted to the affected hand shrinks in CRPS patients, and the degree of shrinkage correlates strongly with how much pain and sensitivity the patient reports.²¹ This cortical reorganization is thought to be both a consequence and a driver of the pain state, creating a feedback loop where the brain’s distorted body map reinforces abnormal signaling.

The brain’s stress-response system is also affected. The hypothalamic-pituitary-adrenal (HPA) axis, the hormonal cascade that controls cortisol release and serves as a brake on inflammation, has been studied in CRPS patients. Researchers examined cortisol levels in saliva, looking at whether this natural anti-inflammatory feedback loop is functioning normally.²² If the HPA axis underperforms, the body loses one of its key mechanisms for tamping down inflammation, which could help explain why CRPS patients experience an exaggerated and self-perpetuating inflammatory state. This is another route through which CRPS could indirectly affect organ systems: not by spreading to them, but by undermining the body’s central hormonal controls that normally keep inflammation in check everywhere.

Testing for Autonomic Dysfunction in CRPS

Given that autonomic dysfunction appears to be the main pathway through which CRPS produces organ-level effects, identifying it early matters. Clinical testing can include sweat output measurement, blood pressure changes during forced breathing maneuvers, heart rate response to deep breathing, and tilt-table testing to check how the cardiovascular system handles position changes.²³ Research has specifically aimed to determine how common autonomic dysfunction is in CRPS using combined tests that probe both the sympathetic and parasympathetic branches.²⁴

If you have CRPS and are experiencing symptoms like dizziness when standing, rapid heart rate at rest, digestive trouble, or unusual sweating patterns, asking for formal autonomic testing is reasonable. These tests are painless and can help distinguish autonomic dysfunction from other conditions that produce similar symptoms, like thyroid disease or medication side effects.

Treatments That Target the Autonomic Component

One of the most encouraging implications of the autonomic connection is that treating it may improve both the limb symptoms and the organ-level effects simultaneously. Animal research has demonstrated that selectively modulating autonomic nervous system activity after a limb injury reduces pain behaviors and limits the immune activation that supports ongoing pain.²⁵

In humans, dorsal root ganglion stimulation, a technique that delivers mild electrical signals to nerve clusters near the spine, has shown intriguing results. In one study, this stimulation reduced sympathetic nerve activity by about 13% and produced a sustained drop in blood pressure over two years of follow-up, with average reductions of roughly 18 points systolic and 11 points diastolic in patients who received left-sided implants.²⁶ That a pain intervention can produce measurable changes in cardiovascular function underscores just how tightly CRPS pain and autonomic regulation are linked. It also opens the door to treatments that address the whole-body burden of the syndrome rather than just the limb it started in.

The cardiovascular improvements seen with pain treatment in these studies echo the earlier heart rate variability findings: when CRPS pain goes down, autonomic balance improves and cardiovascular regulation recovers. For patients dealing with both limb pain and systemic symptoms, this offers a coherent treatment target rather than chasing organ-specific complaints one by one.